A Study Comparing the Pharmacokinetic and Pharmacodynamic Profiles for Sitagliptin, Saxagliptin and Vildagliptin in Patients With Type 2 Diabetes Mellitus (T2DM) (MK-0431-142)
This study has been completed.
Study NCT01582308
Information provided by Merck
First Received on April 19, 2012.
Last Updated on January 4, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
